Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1975 2
1976 3
1977 6
1978 3
1980 4
1981 2
1982 3
1983 5
1984 1
1985 4
1986 6
1987 5
1988 7
1989 4
1990 7
1991 5
1992 5
1993 11
1994 9
1995 15
1996 18
1997 13
1998 17
1999 15
2000 19
2001 20
2002 30
2003 37
2004 23
2005 34
2006 38
2007 39
2008 43
2009 49
2010 46
2011 43
2012 60
2013 55
2014 57
2015 65
2016 43
2017 28
2018 53
2019 34
2020 36
2021 46
2022 45
2023 41
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

1,044 results

Results by year

Filters applied: . Clear all
Page 1
Venetoclax: A new wave in hematooncology.
Mihalyova J, Jelinek T, Growkova K, Hrdinka M, Simicek M, Hajek R. Mihalyova J, et al. Exp Hematol. 2018 May;61:10-25. doi: 10.1016/j.exphem.2018.02.002. Epub 2018 Mar 2. Exp Hematol. 2018. PMID: 29477371 Free article. Review.
Venetoclax is also active in multiple myeloma patients, especially in those with translocation t(11;14), even if high-risk features such as del17p are also present. Surprisingly, positive results are being obtained in elderly acute myeloid leukemia patients, in whom inhibi …
Venetoclax is also active in multiple myeloma patients, especially in those with translocation t(11;14), even if high-risk features s …
Immunomodulatory drugs in AL amyloidosis.
Jelinek T, Kufova Z, Hajek R. Jelinek T, et al. Crit Rev Oncol Hematol. 2016 Mar;99:249-60. doi: 10.1016/j.critrevonc.2016.01.004. Epub 2016 Jan 15. Crit Rev Oncol Hematol. 2016. PMID: 26806146 Review.
Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility.
Celichowski P, Turi M, Charvátová S, Radhakrishnan D, Feizi N, Chyra Z, Šimíček M, Jelínek T, Bago JR, Hájek R, Hrdinka M. Celichowski P, et al. J Transl Med. 2023 Mar 15;21(1):197. doi: 10.1186/s12967-023-04041-6. J Transl Med. 2023. PMID: 36922828 Free PMC article. Review.
Cancer immunotherapies utilizing genetically engineered T cells have emerged as powerful personalized therapeutic agents showing dramatic preclinical and clinical results, particularly in hematological malignancies. ...This comprehensive literature review aims to provide a …
Cancer immunotherapies utilizing genetically engineered T cells have emerged as powerful personalized therapeutic agents showing dram …
Recognition tunneling.
Lindsay S, He J, Sankey O, Hapala P, Jelinek P, Zhang P, Chang S, Huang S. Lindsay S, et al. Nanotechnology. 2010 Jul 2;21(26):262001. doi: 10.1088/0957-4484/21/26/262001. Epub 2010 Jun 4. Nanotechnology. 2010. PMID: 20522930 Free PMC article. Review.
Human dirofilariasis.
Jelinek T, Schulte-Hillen J, Löscher T. Jelinek T, et al. Int J Dermatol. 1996 Dec;35(12):872-5. doi: 10.1111/j.1365-4362.1996.tb05054.x. Int J Dermatol. 1996. PMID: 8970844
Oral treatment with diethylcarbamazine (DEC) (2 mg per kg t.i.d.) over a period of 4 weeks was added to the surgical treatment in all patients. ...
Oral treatment with diethylcarbamazine (DEC) (2 mg per kg t.i.d.) over a period of 4 weeks was added to the surgical treatment in all …
Update on PD-1/PD-L1 Inhibitors in Multiple Myeloma.
Jelinek T, Paiva B, Hajek R. Jelinek T, et al. Front Immunol. 2018 Nov 16;9:2431. doi: 10.3389/fimmu.2018.02431. eCollection 2018. Front Immunol. 2018. PMID: 30505301 Free PMC article. Review.
Visual false memories in posttraumatic stress disorder.
Moradi AR, Heydari AH, Abdollahi MH, Rahimi-Movaghar V, Dalgleish T, Jobson L. Moradi AR, et al. J Abnorm Psychol. 2015 Nov;124(4):905-17. doi: 10.1037/abn0000109. Epub 2015 Sep 21. J Abnorm Psychol. 2015. PMID: 26390193
The Scenic False Memory paradigm (SFM, Hauschildt, Peters, Jelinek, & Moritz, 2012) was administered to male Iranian military personnel who had participated in the Iran-Iraq war and were diagnosed with (n = 21) or without (n = 21) PTSD and a sample of healthy male non- …
The Scenic False Memory paradigm (SFM, Hauschildt, Peters, Jelinek, & Moritz, 2012) was administered to male Iranian military per …
1,044 results